Locations
United States · Philadelphia, PA, USA
industry
Biotechnology
Size
1 - 10 employees
Stage
Other
founded in
2015
Excision Biotherapeutics Inc. is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. We are focused on developing gene editing medicines to eradicate or disrupt viral genes in human patients. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals. The company was founded in 2015 and has already produced a considerable intellectual property portfolio covering the use of CRISPR and other gene editing tools in relation to our targeted pipeline of indications.
Something looks off?